Mission Wealth Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,000
Closed -$9.6K 584
2023
Q2
$9.6K Hold
10,000
﹤0.01% 547
2023
Q1
$7.5K Hold
10,000
﹤0.01% 534
2022
Q4
$3.69K Hold
10,000
﹤0.01% 522
2022
Q3
$4K Hold
10,000
﹤0.01% 509
2022
Q2
$8K Hold
10,000
﹤0.01% 512
2022
Q1
$13K Hold
10,000
﹤0.01% 534
2021
Q4
$13K Hold
10,000
﹤0.01% 537
2021
Q3
$22K Hold
10,000
﹤0.01% 509
2021
Q2
$38K Hold
10,000
﹤0.01% 488
2021
Q1
$33K Hold
10,000
﹤0.01% 442
2020
Q4
$34K Hold
10,000
﹤0.01% 408
2020
Q3
$41K Hold
10,000
﹤0.01% 359
2020
Q2
$34K Hold
10,000
﹤0.01% 334
2020
Q1
$23K Hold
10,000
﹤0.01% 293
2019
Q4
$36K Hold
10,000
﹤0.01% 336
2019
Q3
$83K Hold
10,000
0.01% 315
2019
Q2
$86K Hold
10,000
0.01% 317
2019
Q1
$107K Hold
10,000
0.01% 309
2018
Q4
$88K Hold
10,000
0.01% 271
2018
Q3
$168K Hold
10,000
0.02% 275
2018
Q2
$210K Hold
10,000
0.03% 248
2018
Q1
$161K Hold
10,000
0.03% 226
2017
Q4
$190K Hold
10,000
0.03% 219
2017
Q3
$141K Hold
10,000
0.03% 200
2017
Q2
$75K Hold
10,000
0.01% 189
2017
Q1
$65K Buy
+10,000
New +$55.9K 0.01% 190

Mission Wealth Management's SPPI Position: Q3 2023 in Review

Mission Wealth Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 10,000 shares — an estimated $9.6K sold.

Mission Wealth Management first reported a position in SPPI in Q1 2017 and held it in 26 quarters. The position peaked at $210K in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Mission Wealth Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Mission Wealth Management sold 10,000 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $9.6K.
  • Mission Wealth Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2017 and held it in 26 quarters.
  • Mission Wealth Management's Spectrum Pharmaceuticals Inc position peaked at $210K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Mission Wealth Management's 13F filing for Q3 2023, filed 24 Oct 2023.